Two truncating variants in FANCC and breast cancer risk.
;
Hoda
Anton-Culver
;
Volker
Arndt
;
+162 more...
Kristan J
Aronson
;
Annelie
Augustinsson
;
Laura E Beane
Freeman
;
Matthias W
Beckmann
;
Alicia
Beeghly-Fadiel
;
Sabine
Behrens
;
Marina
Bermisheva
;
Carl
Blomqvist
;
Natalia V
Bogdanova
;
Stig E
Bojesen
;
Hiltrud
Brauch
;
Hermann
Brenner
;
Barbara
Burwinkel
;
Federico
Canzian
;
Tsun L
Chan
;
Jenny
Chang-Claude
;
Stephen J
Chanock
;
Ji-Yeob
Choi
;
Hans
Christiansen
;
Christine L
Clarke
;
Fergus J
Couch
;
Kamila
Czene
;
Mary B
Daly
;
Isabel
Dos-Santos-Silva
;
Miriam
Dwek
;
Diana M
Eccles
;
Arif B
Ekici
;
Mikael
Eriksson
;
D Gareth
Evans
;
Peter A
Fasching
;
Jonine
Figueroa
;
Henrik
Flyger
;
Lin
Fritschi
;
Marike
Gabrielson
;
Manuela
Gago-Dominguez
;
Chi
Gao
;
Susan M
Gapstur
;
Montserrat
García-Closas
;
José A
García-Sáenz
;
Mia M
Gaudet
;
Graham G
Giles
;
Mark S
Goldberg
;
David E
Goldgar
;
Pascal
Guénel
;
Lothar
Haeberle
;
Christopher A
Haiman
;
Niclas
Håkansson
;
Per
Hall
;
Ute
Hamann
;
Mikael
Hartman
;
Jan
Hauke
;
Alexander
Hein
;
Peter
Hillemanns
;
Frans BL
Hogervorst
;
Maartje J
Hooning
;
John L
Hopper
;
Tony
Howell
;
Dezheng
Huo
;
Hidemi
Ito
;
Motoki
Iwasaki
;
Anna
Jakubowska
;
Wolfgang
Janni
;
Esther M
John
;
Audrey
Jung
;
Rudolf
Kaaks
;
Daehee
Kang
;
Pooja Middha
Kapoor
;
Elza
Khusnutdinova
;
Sung-Won
Kim
;
Cari M
Kitahara
;
Stella
Koutros
;
Peter
Kraft
;
Vessela N
Kristensen
;
Ava
Kwong
;
Diether
Lambrechts
;
Loic Le
Marchand
;
Jingmei
Li
;
Sara
Lindström
;
Martha
Linet
;
Wing-Yee
Lo
;
Jirong
Long
;
Artitaya
Lophatananon
;
Jan
Lubiński
;
Mehdi
Manoochehri
;
Siranoush
Manoukian
;
Sara
Margolin
;
Elena
Martinez
;
Keitaro
Matsuo
;
Dimitris
Mavroudis
;
Alfons
Meindl
;
Usha
Menon
;
Roger L
Milne
;
Nur Aishah
Mohd Taib
;
Kenneth
Muir
;
Anna Marie
Mulligan
;
Susan L
Neuhausen
;
Heli
Nevanlinna
;
Patrick
Neven
;
William G
Newman
;
Kenneth
Offit
;
Olufunmilayo I
Olopade
;
Andrew F
Olshan
;
Janet E
Olson
;
Håkan
Olsson
;
Sue K
Park
;
Tjoung-Won
Park-Simon
;
Julian
Peto
;
Dijana
Plaseska-Karanfilska
;
Esther
Pohl-Rescigno
;
Nadege
Presneau
;
Brigitte
Rack
;
Paolo
Radice
;
Muhammad U
Rashid
;
Gad
Rennert
;
Hedy S
Rennert
;
Atocha
Romero
;
Matthias
Ruebner
;
Emmanouil
Saloustros
;
Marjanka K
Schmidt
;
Rita K
Schmutzler
;
Michael O
Schneider
;
Minouk J
Schoemaker
;
Christopher
Scott
;
Chen-Yang
Shen
;
Xiao-Ou
Shu
;
Jacques
Simard
;
Susan
Slager
;
Snezhana
Smichkoska
;
Melissa C
Southey
;
John J
Spinelli
;
Jennifer
Stone
;
Harald
Surowy
;
Anthony J
Swerdlow
;
Rulla M
Tamimi
;
William J
Tapper
;
Soo H
Teo
;
Mary Beth
Terry
;
Amanda E
Toland
;
Rob AEM
Tollenaar
;
Diana
Torres
;
Gabriela
Torres-Mejía
;
Melissa A
Troester
;
Thérèse
Truong
;
Shoichiro
Tsugane
;
Michael
Untch
;
Celine M
Vachon
;
Ans MW van den
Ouweland
;
Elke M van
Veen
;
Joseph
Vijai
;
Camilla
Wendt
;
Alicja
Wolk
;
Jyh-Cherng
Yu
;
Wei
Zheng
;
Argyrios
Ziogas
;
Elad
Ziv
;
ABCTB Investigators
;
NBCS Collaborators
;
Alison M
Dunning
;
Paul DP
Pharoah
;
Detlev
Schindler
;
Peter
Devilee
;
Douglas F
Easton
;
(2019)
Two truncating variants in FANCC and breast cancer risk.
SCIENTIFIC REPORTS, 9 (1).
12524-.
ISSN 2045-2322
DOI: 10.1038/s41598-019-48804-y
Fanconi anemia (FA) is a genetically heterogeneous disorder with 22 disease-causing genes reported to date. In some FA genes, monoallelic mutations have been found to be associated with breast cancer risk, while the risk associations of others remain unknown. The gene for FA type C, FANCC, has been proposed as a breast cancer susceptibility gene based on epidemiological and sequencing studies. We used the Oncoarray project to genotype two truncating FANCC variants (p.R185X and p.R548X) in 64,760 breast cancer cases and 49,793 controls of European descent. FANCC mutations were observed in 25 cases (14 with p.R185X, 11 with p.R548X) and 26 controls (18 with p.R185X, 8 with p.R548X). There was no evidence of an association with the risk of breast cancer, neither overall (odds ratio 0.77, 95%CI 0.44-1.33, p = 0.4) nor by histology, hormone receptor status, age or family history. We conclude that the breast cancer risk association of these two FANCC variants, if any, is much smaller than for BRCA1, BRCA2 or PALB2 mutations. If this applies to all truncating variants in FANCC it would suggest there are differences between FA genes in their roles on breast cancer risk and demonstrates the merit of large consortia for clarifying risk associations of rare variants.
-
picture_as_pdf - Two-truncating-variants-in-FANCC-and-breast-cancer-risk.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution 3.0